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Abstract
Background: Heroin injection is emerging as a significant dimension of the HIV epidemic in Kenya. Preventing
transitions to injecting drug use from less harmful forms of use, such as smoking, is a potentially important focus
for HIV prevention. There is, however, little evidence to support comprehensive programming in this area, linked to
a shortage of analysis of the social and structural context for transitions, particularly in low-income settings. We
explore accounts of transitions from smoking to injecting in Kenya to understand the role of individual, social and
structural processes.
Methods: We combine data from two separate studies conducted in Kenya: an in-depth qualitative study of HIV
care access for people who inject drugs (study 1) and an ethnographic study of the political economy of
the heroin trade in Kenya (study 2). In-depth interviews with PWID and community observation from study 1 are
triangulated with accounts from stakeholders involved in the heroin trade and documentary data from study 2.
Results: People who inject drugs link transitions to injecting from smoking to a range of social and behavioural
factors, as well as particular aspects of the local drug supply and economy. We present these results in the form
of two narratives that account for factors shaping transitions. A dominant narrative of ‘managing markets and
maintaining a high’ results from a process of trying to manage poverty and a shifting heroin supply, in the context
of deepening addiction to heroin. A secondary narrative focuses on people’s curiosity for the ‘feeling’ of injecting,
and the potential pleasure from it, with less emphasis on structural circumstances.
Conclusions: The narratives we describe represent pathways through which structural and social factors interact
with individual experiences of addiction to increase the risk of transitions to injecting. In response, HIV and harm
reduction programmes need combinations of different strategies to respond to varied experiences of transitions.
These strategies should include, alongside behaviour-oriented interventions, structural interventions to address
economic vulnerability and the policing of the drug supply.
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Background
Increasing numbers of people in Kenya are injecting
drugs, with estimates suggesting there are 18,000 people
injecting heroin, with a human immunodeficiency virus
(HIV) prevalence amongst this population of 18 % for
men and 44 % for women [1]. There are also reportedly
high numbers of people smoking heroin, in a ‘cocktail’
where heroin is mixed with tobacco and ‘bhangi’ (cannabis);
anecdotal reports suggest there are many more people
smoking than injecting heroin. Whilst all methods for
using heroin can be linked with harms, injecting is con-
sidered the most dangerous through its links to multiple
health and social harms [2], including HIV, hepatitis C,
skin and vein damage and arrest and imprisonment. The
Kenyan government with civil society partners has re-
cently introduced harm reduction services for people who
inject drugs (PWID), including needle and syringe ex-
change and opioid substitution therapy. However, there
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are limited strategies available to support those who
smoke heroin, but do not inject, including limited access
to residential rehabilitation and methadone substitution.
Support for people smoking heroin, and in particular sup-
porting the prevention of transitions to injecting drug use,
is therefore a potentially key priority for HIV prevention.
In this paper, we combine insights from two research
studies in Kenya to address key gaps in the literature: tran-
sitions in low- and middle-income countries and then the
role of social and structural factors in these.
The majority of research on transitions delineates indi-
vidual behavioural factors and then interpersonal- or
social-level factors [3, 4]. Such work draws attention to
how injecting becomes acceptable, even appealing,
through social interaction [5] and how injecting is
demonstrated and inspired by social contacts [6, 7].
Overlapping with this is a concern for curiosity and plea-
sure [5, 7] or ‘the rush’ of injecting as compared to other
modes of use [8]. Alongside pleasure is a concern to inject
so as to use heroin more economically [6, 7]. This litera-
ture has also drawn attention to the potentially greater
vulnerability of women to transitions [9, 10] and of youn-
ger people [7]. Transitions can, however, perhaps be most
usefully understood as shaped by a ‘constellation’ of fac-
tors from the personal, socio-economic and political
spheres [6, 11]. The role of macro-level, structural factors
such as the role of drug supply shifts and policing [12–14]
but also the political-economic context and impact of
social and economic change [15, 16] is less of a focus in
current literature. Research in low- and middle-income
settings is also limited [6, 7, 12, 15].
Available interventions reflect this focus of research by
being oriented towards addressing individual behaviour
and discouraging peer influence within social networks
[2, 17, 18]. Whilst such interventions are potentially
valuable, in isolation, they risk ignoring the role of the
social and structural environment in producing in-
creased risk for transitions. There is now a rich tradition
of research highlighting the role of the structural and so-
cial environment in creating risk for harm from drugs,
as critique of analysis focusing solely on individual and
behavioural determinants of harm [11, 19, 20]. The risk
of harm from practices such as injecting drugs are, from
this perspective, shaped by interactions between individ-
uals and their environment, where structural factors
constrain and enable different choices [19]. Transitions
to injecting can therefore be understood as shaped by
how expectations and understandings of injecting drug
use, stigma, economic pressures and other factors with
influence emerge from an individual’s experience of par-
ticular social conditions.
An exploration of social and structural influences on
transitions from smoking to injecting heroin in Kenya
emerged from discussion of initial findings from a
qualitative longitudinal study of HIV care access (the
Access2Care study; Kenya AIDS NGOs Consortium,
London School of Hygiene and Tropical Medicine and
International HIV/AIDS Alliance). Through early phases
of the study, people who inject drugs spoke about the
role of friends, poverty, shifts in the local tourist econ-
omy and shifts in the drug supply as key influences in
transitioning from smoking to injecting heroin. The
Access2Care study was implemented at the same time as
the Heroin Trade study. Discussions between the two
teams indicated the value in combining analyses to ex-
plore in detail how structural processes, such as an
evolving drug supply and the policing of it, impact on
transitions. Context for the development of these themes
of enquiry was past research in Kenya reporting a major
shift in the heroin supply from ‘brown sugar’ to ‘white
crest’ heroin in the early 2000s, which in turn led to a
widespread shift from chasing to injecting [12, 21] and
more recent reports of interruptions to the drug supply
influencing transitions [22]. Through conversations
across the research teams facilitated by the London
International Development Centre, we identified an op-
portunity to triangulate our findings and explore the
contexts that produce increased risk for transitions fur-
ther. In the rest of this paper, we report key themes from
the Access2Care study in PWID accounts of their transi-
tions and then triangulate this with detailed analysis of
the drug supply from the Heroin Trade study. Under-
standing the role of these social and structural factors in
shaping drug use is an urgent public health priority and
could inform harm reduction strategies in Kenya and
similar settings across the region.
Methods
This paper combines data from two independent studies:
the Access2Care (A2C) study (TR, JN, AG) and the Her-
oin Trade study (MD, PC). Both studies had an iterative
research design, to allow in-depth exploration of a focus
area: HIV care access and the political economy of the
heroin trade in Kenya. We combined insights through
two steps: (i) consultation on the developing analysis of
the A2C study to allow further exploration of emerging
hypotheses within the ongoing implementation of that
longitudinal study and (ii) triangulation of data in the
final analysis.
The Access2Care study was a longitudinal qualita-
tive study working with PWID in three sites across
Kenya—Nairobi, Malindi and Ukunda—from Dec 2012
to June 2014. In-depth ethnographic PWID interviews, in-
terviews with community stakeholders and observation in
community settings explored experiences of HIV care.
Within these interviews and observations, accounts of
transitions were raised by respondents alongside explor-
ation of HIV treatment and prevention, needle and syringe
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use, drug treatment and other issues. Across the study, we
interviewed 118 individuals, including a purposive sample
of 33 people who were interviewed over three waves (wave
1 was Dec 2012/Jan 2013, with follow-ups at 6 and
12 months). Interviews were done by TR, JN, AG and out-
reach workers trained in qualitative interviewing. Sam-
pling purposively sought a range of experiences of HIV
care and injecting drug use by both genders. Interviews
were conducted in English or Kiswahili, depending on the
language skills and preference of the interviewee. Interviews
were shaped by context: we sought to respond to the issues
raised by respondents, and interviews were done in com-
munity settings, sometimes drug-using sites, and were lim-
ited and often shortened by the contingencies of drug use
and addiction: withdrawals, hunger or the threat of arrest.
It was within this research design and context that transi-
tions as shaped by the social and structural context
emerged in respondents interviews. Fifty PWID offered ac-
counts of their transitions from smoking to injecting heroin,
varying from brief utterances of a single factor to extended
multi-layered accounts. We focus analysis on these ac-
counts, relating in turn to the views of other respondents
and stakeholders in exploring the context for them. Study
participant characteristics are summarised in Table 1.
The Heroin Trade study was conducted over 8 months
in multiple heroin distribution and consumption locations
in Nairobi and throughout the coast of Kenya (and so in-
cluding Malindi and Ukunda as cited for the Access2Care
study) in 2013 and 2014 (and so, at the same time as the
A2C study) by MD and PC. It relied on ethnographic
methods to document interpersonal relations amongst
drug merchants, community members and law enforcers
through the field researcher’s immersion in the everyday
lives of these populations. This produced a total of 132 in-
depth, semi-structured interviews with 92 respondents in
Kiswahili. A summary of participants is included in Table 1.
Participant observation and critical document analysis
supplemented these interviews.
Each study separately followed principles of thematic
analysis [23], with emergent themes the focus for
discussion between the teams, as part of an ongoing it-
erative process of analysis. In the analysis presented, we
use findings from the A2C study to give insight into
PWID experiences and then critically explore them with
reference to contextual data from the A2C and Heroin
Trade studies. Both studies secured relevant ethical
approval, with the Access2Care study approved by the
University of Nairobi and the London School of Hygiene
and Tropical Medicine, whilst the Heroin Trade study was
approved by the University of London. All participants
provided informed consent, and names used in the text
are pseudonyms to protect anonymity.
Results
In the A2C study, PWID narrated their transitions from
smoking to injecting by referring to a range of factors or
processes. For example:
“R: Sometimes I see them, they are ten new comers
who come from smoking to inject […]You know why,
like me, the way how I get injected, I smoked a lot
and I don’t feel anything. But these drugs we are
taking is not real heroin, it is just chemicals.....so
people they see us, we inject, we feel good and don’t
spend a lot of money.” (Sandra, PWID, Ukunda, A2C)
Sandra’s account was typical for how it weaved to-
gether a combination of influential factors at the indi-
vidual (‘I don’t feel anything’), social (‘they see us, we
inject’) and structural level (the drug supply is of low
quality). Key themes across the A2C study accounts fo-
cused on the active role of friends in promoting inject-
ing, deciding to inject and managing risk, the feeling,
the quality and the cost. These themes then overlapped
with accounts of the context: that of poverty for people
using drugs in the A2C study and that of a shifting drug
supply and how it is policed from the Heroin Trade
study.
These overlapping themes combine around two princi-
pal narratives that account for transitions: first, that of
Table 1 Summary of participant characteristics for the two studies
Access2Care
PWID reporting transitions: N = 50 Age (mean) and range 31 (22–45)
Gender 13 women (26 %), 37 men (74 %)
HIV status 15 living with (30 %)
Of the overall sample of 118, there were 84 men (71 %)/32 women (29 %) and 44 PLHIV (37 %), with an age range of 31 (19–49)
Stakeholders: n = 12 7 male, 5 female—2 outreach project managers, 5 outreach workers, 2 outreach-based clinical officers,
1 clinical-based clinical officer, 2 outreach-based HIV counsellors
Heroin Trade study
Drug merchants: n = 35 32 male, 3 female, all participating in the informal, criminal economy
Stakeholders: n = 57 54 men, 3 women, from police, government departments, rehabilitation centres and community organisations
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‘managing the market and maintaining a high’ and a second
of ‘the feeling of injecting’. We identified these narratives
from the 50 PWID who discussed their transitions in the
Access2Care study. As demonstrated in Table 1, these par-
ticipants were mostly male (37, 74 %/13 women, 26 %),
with an average age of 31, and 15 from this group were
living with HIV; these characteristics are similar to those
of the overall study sample, and in line with the key trends
in Kenya of principally being men who inject drugs, with a
high prevalence of HIV across the population. We outline
these two narratives here, exploring how individual expe-
riences are grounded in the social context.
Managing the market and maintaining a high
A dominant narrative across the A2C study—figuring
across 29 of the 50 accounts—was of a transition to
injecting grounded in consideration of the material cir-
cumstances of money and the drug supply. Reflecting
how economic concerns are central to organising daily
life, people spoke of wanting a high, to recover from
withdrawals or a growing tolerance for heroin in terms
of the efficiency of injecting and how to balance struc-
tural changes in the economy and drug supply. For
many, injecting was valued over smoking for how it
allowed you to ‘stay until evening without taking another
sachet’ (Joseph, Nairobi), or the high lasted for 8 hours,
rather than 4 hours for smoking. This focus on time and
the length of a high—not its intensity—is a function of
the punishing cycle of looking for money, which occupied
much of people’s daily life. Rather than ‘slaving’ to get
enough money to smoke you could inject (Pep, Nairobi)
and so avoid the ‘slaving’, or ‘hustling’ for money that was
time-intensive, physically demanding and often brought
little money. As well as the duration of a high was how
smoking heroin could be reconciled with the other costs
of daily life in the context of money shortages:
“I: what made them to join the injection?
R: its depending on the amount of money one is
getting. You know some are getting a thousand
[shillings] per day [approx. $10]. So this one thousand…
if they [the dealers] sell drugs like one hundred and fifty
[shillings], four drugs are six hundred shillings, and in
the evening he is required to pay a room with two
hundred, because he cannot sleep outside, so in that
one thousand if you remove six hundred for drugs, and
two hundred for a room, you will remain with two
hundred for food.” (Haj, Nairobi)
A daily process of seeking money to address first the need
for drugs, then shelter and then food was difficult and cre-
ated an economic pressure to inject. As Isaiah, from Ukunda,
said, injecting is cheaper, you do not ‘waste’ money.
Overlapping with a concern for cost, PWID spoke
about how shifts in the quality of available heroin were
central in their transitions. Echoing the findings of
Beckerleg et al. [12], the historical shift from brown sugar
to white crest heroin was cited by some as structuring
their transition. This abrupt historical shift in supply has
now given way to more regular fluctuations in the quality:
“I: You were smoking, why did you start injecting?
R: Okay sometimes it’s with the drug you know. This
drug in the market it doesn’t have that kick, you
know, the kick you want, you see. Now you see, the
only way you are going to use it is by injecting, that’s
when you will feel it maybe. So you end up injecting
yourself, you see.” (Charo, Nairobi)
PWID spoke of how the heroin they bought was
mixed with other substances, such as caffeine, dust and
even biscuits. More needed to be bought or a different
method found for administration.
A transition often figured as a highly managed process.
There were isolated accounts where people spoke of con-
fusion and feeling out of control, but more were spoken of
as active decisions based on considerations of benefits or
circumstances, albeit under considerable pressure:
“R: I smoked and reluctantly I decided to start injecting’
I: maybe it is somebody who introduced you?
R: I wanted it myself
I: you wanted to start?
R: I felt reluctant and decided to inject because anytime
I smoke I spend a lot of money.” (Naomi, Ukunda)
For some, transitions were presented as a solution to a
particularly acute shortage of money and had only
intended to inject for just 1 day. Friends who already
injected, or others in the highly public drug-using scene,
were also identified in this process of decision making:
sometimes this was the passive example from others, but
friends were also described as proactively advocating the
cost benefits of injecting as compared to smoking and
then also helping by administering the first injection.
The risk to health from injecting was sometimes ac-
knowledged in the context of these transitions; some re-
ported not being aware of HIV and other harms from
injecting, but the majority expressed some awareness of
the risks from needle sharing and then overdose. This
risk of HIV was often managed: people would pur-
posively buy or source a new needle and syringe, with
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friends and others injecting figuring centrally in this
process. There were only isolated accounts of people
spontaneously deciding to inject and using a used needle
and syringe.
The context of economic hardship: a dangerous, marginal
position
The experience of daily life and a transition as a series of
calculations over the availability of money and resources
emerges from drug users’ marginal position in local econ-
omies. Any work that is available is informal, uncertain
and often linked to physical risk. Across the A2C study,
people often spoke of money, employment and the chal-
lenges of everyday survival as their priority, rather than
the risk of HIV or other health and social concerns. In the
absence of formal or reliable sources of income—denied
through a combination of not being trusted, not being
physically able to work or not being able to organise work
within the demands of addiction—people engaged in shift-
ing combinations of informal work: from carrying luggage
at markets or sex work to petty crime. Getting money
often involved time-intensive and demanding work:
‘difficult, yeh, difficult, you have to toil, you really have to
toil. Like today I woke up around 5:30 in the morning be-
cause I don’t want the rush hour to end before I get the
money that I want’ (Charo, Nairobi). Getting money was
often dangerous, linked to petty crime as a focus for many.
The majority of those interviewed across the A2C sample
had experienced ‘mob justice’: physical violence from the
community in response to real or perceived crime. A
reliance on crime or informal work reflects an overriding
experience of economic isolation: most had limited con-
tact with family and there were few, if any, economic
safety sets.
The structures of local economies featured not just mar-
ginal work for people who used drugs but economic cycles
that exacerbated vulnerability and created particular acute
financial pressures. In Malindi and Ukunda, and for much
of coastal Kenya, the economic cycle is dominated by sea-
sonal variations of tourism. The low tourist season is a
particularly difficult time of the year to get money and as
a result was linked with people transitioning:
“I: is there a lot of other people who have just started
injecting?
R: yeah, I believe, some, there are some, there is a big
group who are doing secretly, because at the moment
you see the climate it’s very rainy and at the beach
there are no guests, so coming to get money it’s very
hard.” (Victor, Ukunda)
Whether through formal work in hotels, selling souve-
nirs or sex or seeking donations, many were reliant on
how the tourism industry would trickle down through
the local economy. With pre-existing economic vulner-
ability, people were reportedly unable to manage these
structural shifts.
The context for a shifting supply: insight from the Heroin
Trade study
The concurrent Heroin Trade study provides detailed
insight into the shifts in the quality of heroin PWID de-
scribe in the Access2Care study. Structural characteristics
of the Kenyan drug supply shape the fluctuating cost and
quality of heroin. More heavily policed—and thus diversi-
fied and fragmented—supply routes through and into East
Africa reflect global illicit drug shipment patterns [24].
Whilst historically the heroin supply in Kenya may have
been consolidated around a few suppliers, interviews with
those involved in distribution demonstrate there has been
a fragmentation of vertical chains of supply and emer-
gence of small, ad hoc smuggling operations and new
routes. In the word of Ndolo who used to sell heroin for
Pakistani smugglers throughout the world until he finally
settled down in his hometown Mombasa:
“I: So are there any international drug syndicates here?
R: No international syndicates. It’s just people. Right
now, I have my own capital, 20,000. This is enough to
buy 10 grams. I go to buy 10 grams, if I sell them, I
keep the profit. I just have to look for someone to sell
[for me], ‘Take this, sell it’, ‘Take that, sell it’. That’s it.
You hear a lot about ‘companies’, but they are not real
companies.” (Ndolo, Mombasa)
Indeed, an increasing number of dealers are operating
independently or working for a number of distribution
operations. China, a respondent from Nairobi, used to
work for one organisation as stock-keeper and ‘lab’ as-
sistant processing heroin for 3 years. He subsequently
started freelancing after disagreements emerged between
him and his superior. In his words, chains of supply cut
across distribution units, creating a networked drug
supply, rather than strictly vertical hierarchies:
“R: This thing is like a chain, this is my stuff, then I
have my subordinate and then it goes like that to the
end. And the smallest guy…
I: So you think this chain is long?
R: It’s very long because, you see, for example, I have
stuff and you know that I have stuff and you are also a
dealer maybe. I will sell you some, and you probably
have another person that sells to you. That’s how it
goes, you can’t know.” (China, Nairobi)
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The ‘chain’ that China refers to clearly has a vertical
dimension to it but is also extended laterally as various
freelancers and mediators connect different operations.
As a result, top-down movements are interwoven with
lateral ones; units are small, constantly regrouping and
thus lack clear, long-term leadership.
This elongation and complication of the drug supply
overlaps with disruption caused by policing strategies
shaped with reference to Kenya and the region’s increas-
ingly central position in the global War on Drugs and
War on Terror [25, 26]. Recent policing initiatives reflect
this. For example, the Mombasa county governor said
on starting his term in office in 2013: ‘I today declare
drugs a county-disaster and we are committed to fight
it. Give me six months to deal with this drug menace’
[27]. Several chaotic, mass arrest operations in drug-
dealing and using locations took place after this state-
ment was made. The emphasis is on immediate arrests
and deportations with the most visible actors in the her-
oin trade—those operating at the street level—being a
target. In a renewed war on drugs initiative, following
the first wave of counternarcotics activity in 2013,
Mombasa county commissioner Nelson Marwa oversaw
the raiding of 29 dealing locations in Mombasa county
in September 2014. He reiterated a commitment to mak-
ing as many arrests as possible, claiming that his team
‘will not spare anyone’ [28].
The Heroin Trade study documented a series of raids
on one of the most prominent dealing locations on
Mombasa Island, which took place in April 2013. Jay,
former dealer and current stolen goods reseller from the
locale, described the events as follows:
“After the campaign had finished, people got taken
out of here by the police… They came about 4 pm,
they put guards, dogs, they started arresting half of
the people [break] many got arrested, few managed to
run away . […] They burnt down the whole place, the
police and the AP, so people can’t sleep here. Then
they came back at 10 pm and then the following day
too. About five times they came back. So people don’t
sleep here anymore.” (Jay, Mombasa)
These unpredictable episodes of heavy counternarcotics
policing introduce sudden shocks to local markets, dras-
tically diminishing the availability of drugs. During such
periods of intensified law enforcement, prices are likely to
soar. In April 2013, for example, a single-dose sachet of
heroin was sold for 300 Kenyan shillings—double its
stable market price. Acting under international pressure,
political leaders have taken bold steps to securitise the
drug trade in the country. The highly publicised policing
endeavours which are part of a national war on drugs [29],
coupled with the fragmentation of supply networks,
produce a highly fluctuating and unpredictable supply of
heroin. As a female dealer from Mombasa concluded, ‘the
quality of drugs changes every day’.
Managing the market
Out of this shifting, heavily policed drug supply and
marginal position in the local economy, PWID expe-
rience acute economic pressures that need to be man-
aged. That the drug does not give the same ‘kick’ or that
it costs substantially more does not determine a transi-
tion, but in a context of economic vulnerability, with-
drawals and social influence, the decision to inject is one
way in which to cope with these shifts.
The ‘feeling’ of injecting
A secondary narrative across accounts from the A2C
study was of transitions to injecting focused on the ‘the
feeling’ of injecting. This narrative was secondary across
the data, figuring in 21 accounts. Whilst overlapping
with a narrative of managing the market in that both fo-
cused on a ‘high’ and cost and quality factors figured,
here we focus on how the search for ‘more steam’ was
oriented towards the feeling of injecting. For example:
“I: Can you tell me how was it that you started
injecting?
R: Starting injecting, I was seeing that when someone
injected they were getting a lot of steam, they were
feeling happy. I went and asked my friend why is it
that when you inject you passing out so much? And
she told why don’t I try … I told her fine let me try
for today. I tried and felt the sweetness, which is how
I went into it, just like that.
I: Mm, what can you say specifically made you inject?
R: Desire that is…your friend is feeling, desire
I: Okay that first time you were starting to inject, did
you have any concerns about injecting?
R: No, I did not have any concerns, because I wanted
to feel how someone feels when they injected. Because
if it is smoking, I have smoked, if it is sniffing, I have
sniffed, but how does someone feel when they inject?”
(Mary, Ukunda)
Explication of this ‘feeling’ by PWID was limited; there
were references to the high being ‘direct’ and making
you ‘happy’, giving ‘pleasure’ and ‘taking you to the
moon’, whilst the feeling of smoking had subsided with
increasing tolerance. Later, Mary references money, not-
ing the money saved, but this figures as incidental to the
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dominant narrative of the ‘feeling’. Whilst cost and qual-
ity were sometimes mentioned, this was often absent
from these accounts, suggesting a different pattern of
influence from fluctuations in cost and quality, more
indirect, if at all, and a greater emphasis on pleasure and
curiosity.
As with an understanding of cost, the encouragement
of friends and others injecting or wanting to replicate
their experience was often central to accounts. Mary
sought to inject based on observation of, and interaction
with, a friend who was injecting. Tom talked of his sex-
ual partner. He spoke about how he had started smoking
‘cocktails’, and over time, they had stopped making him
high. He then describes the day he first injected and
how he was with a female friend:
“She told me try ‘Tom, this if you inject you will, you
will fuck well, you will have intercourse, you feel
pleasure, you and you will feel…you will enjoy a lot’.
So it was my first time when she injected me, she was
a doctor having a lot of experience and she is not a
doctor for treating patients at the hospital” and later
“but with that injection, it was something fantastic,
the way I love steam, I see this is good.”
Such accounts of others reporting the pleasure and
feeling of injecting and encouraging others were com-
mon. Tom also reported not being aware of the risk of
HIV, but other accounts acknowledged risk, and it again
figured as managed, with people buying or sourcing
clean needles and syringes.
Discussion
Transitions to injecting heroin in our study are described
as multi-layered phenomena, emerging from a combin-
ation of factors to produce specific experiences. In our
analysis, we have presented two narratives through which
factors of deepening addiction, curiosity, the influence of
friends, shifting cost and supply quality combine. Transi-
tions are experienced as a process of managing a series of
resource constraints or of curiosity or search for pleasure.
These narratives present differing experiences of the
social and structural context and how risk for transitions
is created. Particular features of the structural environ-
ment are experienced by some as constraints: a marginal
position for PWID in the economy and particular shifts
in the drug supply, themselves resulting from policing
practices. Transitions as a social practice can therefore
be seen to emerge from how agency is produced and
enacted within these structural pressures through the
creation of a logic of economic constraint that shapes
how transitions are understood and managed [19]. Any
choice to inject is then principally subsumed within an
overall experience of resource constraint and economic
vulnerability and figures to manage constraint rather
than as an expression of freedom [30]. That these struc-
tural economic factors are not determining of transitions
is then demonstrated by how economic vulnerability is
secondary for some, as compared to a pursuit of plea-
sure. Here, a logic of pleasure emerges from the specific
experience of a social network, whether through seeing
others inject or being encouraged to inject. Our analysis
therefore points towards the co-existence of differing ef-
fects of social and structural pressures, and so how risk
is produced, based on the specificity of an individual’s
experience and situation in relation to them.
These conclusions have implications for efforts to pro-
vide interventions in support of preventing transitions to
injecting: of the need to respond to different experi-
ences, and how, within this, there is a need to respond
to structural as well as behavioural determinants of risk.
For example, options other than a transition to injecting
are needed as a strategy to manage long-term and acute
poverty, such as livelihood support and more widespread
drug treatment programmes. Responses to the poverty
experienced by people who use drugs are also a priority
to respond to how local economic cycles impact on
PWID. The role of global and national economic policies
and institutions in fostering local economic conditions
should be a focus for further analysis with reference to
responses to drug related harms (as well as their role in
general economic uncertainty for the general population).
Addressing poverty could include expansion of livelihood
programmes as already in development in Kenya [31] and
regulation and formalisation of tourist economies.
Interventions to address the fluctuating drug supply are
limited by the nature of illegal organisations and the com-
plex dynamics of policing them. However, this analysis
does suggest that the current emphasis on criminalising
low- and mid-level dealers, as well as users, has direct re-
percussions in leading to transitions, through creating an
unreliable supply. In Kenya, anti-narcotics policing has re-
cently centralised [32] increasing the likelihood of crimin-
alisation of petty street-level dealers and, more frequently,
heroin users, who are easy targets for regular police offi-
cers. Efforts towards supply-reduction could also cause
longer term shifts in supply—as with the shift from brown
sugar to white crest—with similar influences on modes of
use. As such, emphasis should be placed on greater align-
ment at a strategic level between interdiction and health
and social policy to ensure more emphasis on the latter to
direct policing interventions that would minimise the
harms of efforts to control supply. This could include a re-
duction in ‘low-level’ arrests and more focus on investigat-
ing networks as opposed to making ostentatious ‘small
fish’ seizures and arrests. In addition, the development of
clear emergency protocols to manage abrupt shifts in the
drug supply is a priority [22].
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For those whose experience is shaped by curiosity and
pleasure, action on economic constraints or the drug
supply may have less potential preventative impact. In-
stead, interventions that address the influence of a local
social network may be of greater relevance [2]. In
addition, engagement in outreach and ongoing counsel-
ling [33] could support the prevention of transitions or
at minimum support them to be of less risk—i.e. a clean
needle and syringe is available, with knowledge of safe
use. A broader acceptance of the role of pleasure, and its
incorporation into public health messaging and re-
sponses, is also essential [8].
A specific issue for further analysis is the increased vul-
nerability of women and the role of gender relations in
creating risk for transitions. Research in other contexts
has demonstrated women often transition in the context
of intimate partnerships [9, 10]. Across our sample,
women reported their transitions around the two narra-
tives we have presented above. There were isolated refer-
ences to boyfriends, but they were not described as
integral to transitions. We did not discern any particular
differences in transitions according to gender. Further
probes within interviews to explore issues of gender in
particular could have potentially identified further insight
here. Additional analysis of how risk for transitions, and
other drug-related harms, is gendered and is structured by
gender relationships in this context is necessary to draw at-
tention to the potential complexity around this issue [34].
This paper has sought to combine different datasets to
give insight to the range of social and structural factors
shaping transitions to injecting. Through this, we have
added to the literature understanding transitions through
qualitatively locating individual experiences in a detailed
account of the heroin supply and surrounding economy
and drawing attention to the role of pleasure.
Relating these datasets to each other is limited by how
researchers hold different perspectives and interpreta-
tions, as well as familiarity with the specific contexts
where data were collected. Nevertheless, ongoing discus-
sion across the team to explore and understand the con-
text for individual sections of data and explore our
individual and then team-based interpretations helped
overcome these challenges.
Conclusions
In conclusion, transitions to injecting heroin in Kenya are
shaped by specific features of the social context, drug
trade and local economy. As harm reduction for people
who inject drugs develops rapidly in Kenya, it is an urgent
priority for HIV prevention to consider the needs of
people who smoke drugs and to develop responses that
can respond to the structural pressures that increase the
risk of transitions.
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